A pre-clinical study showed that digoxin increases intracellular Ca+2 causing changes in the activity of cyclin-dependent kinase Cdk5, cleavage of p35 and formation of p25 leading to prostate cancer cells apoptosis [76]. The gene discussed is CDK5; the disease is prostate carcinoma.